APA (7th ed.) Citation

EK, K., C, V., ECT, G., J, G., JEA, P., M, S., . . . MJHA, K. (2026). Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-Limiting Disease. Thrombosis and haemostasis, 126(7), 714. https://doi.org/10.1055/a-2524-5334

Chicago Style (17th ed.) Citation

EK, Kempers, et al. "Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-Limiting Disease." Thrombosis and Haemostasis 126, no. 7 (2026): 714. https://doi.org/10.1055/a-2524-5334.

MLA (9th ed.) Citation

EK, Kempers, et al. "Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-Limiting Disease." Thrombosis and Haemostasis, vol. 126, no. 7, 2026, p. 714, https://doi.org/10.1055/a-2524-5334.